Overview
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist derived from Melanotan II. This peptide has been investigated in scientific literature for its interactions with melanocortin receptor subtypes (MC1R-MC5R) and its biochemical properties in neuroendocrine signalling models. PT-141 serves as a valuable research tool for studying melanocortin receptor pharmacology, neuropeptide signalling cascades, and related biological pathways in controlled laboratory settings.
RESEARCH USE ONLY. Not for human consumption, injection, or medical treatment. Not approved by the FDA for research purposes.
